Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
References
- Moon DH, Efstathiou JA, Chen RC. What is the best way to radiate the prostate in 2016? Urol Oncol 2017; 35: 59-68. doi: 10.1016/j.urolonc.2016.06.002
- Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009; 93: 226-33. doi: 10.1016/j.radonc.2009.08.011
- Syed YA, Patel-Yadav AK, Rivers C, Singh AK. Stereotactic radiotherapy for prostate cancer: A review and future directions. World J Clin Oncol 2017; 8: 389-97. doi: 10.5306/wjco.v8.i5.389
- Avkshtol V, Dong Y, Hayes SB, Hallman M, Price R, Sobczak M, et al. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol 2016; 8: 145-58. doi: 10.2147/RRU.S58262
- Seppälä J, Suilamo S, Tenhunen M, Sailas L, Virsunen H, Kaleva E, et al. Dosimetric comparison and evaluation of 4 stereotactic body radiotherapy techniques for the treatment of prostate cancer. Technol Cancer Res Treat 2017; 16: 238-45. doi: 10.1177/1533034616682156
- Chen RC. Radiation therapy for prostate cancer: an evolving treatment modality. Urol Oncol 2019; 37: 579-81. doi: 10.1016/j.urolonc.2019.05.023
- Katz A. Stereotactic bodyrRadiotherapy for low-risk prostate cancer: a ten-year analysis. Cureus 2017; 9: e1668. doi: 10.7759/cureus.1668
- McBride SM, Wong DS, Dombrowski JJ, Harkins B, Tapella P, Hanscom H, et al. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial. Cancer 2012; 118: 3681-90. doi: 10.1002/cncr.26699
- MacDougall ND, Dean C, Muirhead R. Stereotactic body radiotherapy in prostate cancer: is rapidarc a better solution than cyberknife? Clin Oncol 2014; 26: 4-9. doi: 10.1016/j.clon.2013.08.008
- Dong P, Nguyen D, Ruan D, King C, Long T, Romeijn E, et al. Feasibility of prostate robotic radiation therapy on conventional C-arm linacs. Pract Radiat Oncol 2014; 4: 254-60. doi: 10.1016/j.prro.2013.10.009
- Lin YW, Lin KH, Ho HW, Lin H, Lin L, Lee S, et al. Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: non-isocentric CyberKnife versus isocentric RapidArc. Phys Med 2014; 30: 654-61. doi: 10.1016/j.ejmp.2014.03.008
- Quan EM, Li X, Li Y, Wang X, Kudchadker R, Johnsosn J, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 2012; 83: 1169-78. doi: 10.1016/j.ijrobp.2011.09.015
- Elith CA, Dempsey SE, Warren-Forward HM. A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer. J Med Radiat Sci 2013; 60: 84-92. doi: 10.1002/jmrs.22
- McGarry CK, Butterworth KT, Trainor C, O’Sullivan JM, Prise KM, Hounsell AR. Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Phys Med Biol 2011; 56: 2445-57. doi: 10.1088/0031-9155/56/8/008
- Kopp RW, Duff M, Catalfamo F, Shah D, Rajecki M, Ahmad K. VMAT vs. 7-Field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Med Dosim 2011; 36: 365-72. doi: 10.1016/j.meddos.2010.09.004
- Davidson MTM, Blake SJ, Batchelar DL, Cheung P, Mah K. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and postoperative prostate cancer. Int J Radiat Oncol Biol Phys 2011; 80: 1550-8. doi: 10.1016/j.ijrobp.2010.10.024
- Salimi M, Shirani K, Abi T, Nedaie H, Hassani H, Gharaati H, et al. Assessment and comparison of homogeneity and conformity indexes in step-and-shoot and compensator-based intensity modulated radiation therapy (IMRT) and three-dimensional conformal radiation therapy (3D CRT) in prostate cancer. J Med Signals Sens 2017; 7: 102-7. PMID: 28553583
- Fischer-Valuck BW, Rao YJ, Michalski JM. Intensity-modulated radiotherapy for prostate cancer. Transl Androl Urol 2018; 7: 297-307. doi: 10.21037/ tau.2017.12.16
- Varnava M, Sumida I, Mizuno H, Shiomi H, Suzuki O, Yoshioka Y, et al. A new plan quality objective function for determining optimal collimator combinations in prostate cancer treatment with stereotactic body radiation therapy using CyberKnife. PLoS ONE 2018; 13. doi: 10.1371/journal.pone.0208086
- Scobioala S, Kittel C, Elsayad K, Kroeger K, Oertel M, Samhouri L, et al. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma. Radiat Oncol 2019; 14. doi: 10.1186/s13014-019-1353-6
- Ceylan C, Kucuk N, Bas Ayata H, Guden M, Engin K. Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer. Rep Pract Oncol Radiother 2010; 15: 181-9. doi: 10.1016/j.rpor.2010.10.003
- McGuinness CM, Gottschalk AR, Lessard E, Nakamura J, Pinnaduwage D, Pouliot J, et al. Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients. J Appl Clin Med Phys 2015; 16: 284-95. doi: 10.1120/jacmp.v16i5.5502
- Menzel HG. The international commission on radiation units and measurements. J ICRU 2010; 10: 1-106. doi: 10.1093/jicru/ndq001
- Park JI, Park JM, Kim J in, Park SY, Ye SJ. Gamma-index method sensitivity for gauging plan delivery accuracy of volumetric modulated arc therapy. Phys Med 2015; 31: 1118-22. doi: 10.1016/j.ejmp.2015.08.005
- Hussein M, Rowshanfarzad P, Ebert MA, Nisbet A, Clark CH. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems. Radiother Oncol 2013; 109: 370-6. doi: 10.1016/j.radonc.2013.08.048
- Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218. Med Phys 2018; 45: e53-83. doi: 10.1002/mp.12810
- R Core Team - European Environment Agency. R software, version 4.0.3. [2020]. Available at https://github.com/tim-lebedkov/packages/releases/download/2020_10/r-4.0.3-R-4.0.3-win.exe
- Hardcastle N, Tomé WA, Foo K, Miller A, Carolan M, Metcalfe P. Comparison of prostate IMRT and VMAT biologically optimised treatment plans. Med Dosimet 2011; 36: 292-8. doi: 10.1016/j.meddos.2010.06.001
- Mellon EA, Javedan K, Strom TJ, Moros E, Biagioli M, Fernandez D, et al. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol 2015; 5: 11-5. doi: 10.1016/j.prro.2014.03.003
- Gleeson I. A comparison of a moderately hypofractionated IMRT planning technique used in a randomised UK external beam radiotherapy trial with an in-house technique for localised prostate cancer. Rep Pract Oncol Radiother 2020; 25: 360-6. doi: 10.1016/j.rpor.2020.03.010
- Kishan AU, King CR. Stereotactic body radiotherapy for low- and intermediate-risk prostate cancer. Semin Radiat Oncol 2017; 27: 268-78. doi: 10.1016/j.semradonc.2017.02.006
Language: English
Page range: 259 - 266
Submitted on: Oct 21, 2021
Accepted on: Jan 31, 2022
Published on: Mar 28, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.